Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Shi, Q; Sobrero, AF; Shields, AF; Yoshino, T; Paul, J; Taieb, J; Sougklakos, I; Kerr, R; Labianca, R; Meyerhardt, JA; Bonnetain, F; Watanabe, T; Boukovinas, I; Renfro, LA; Grothey, A; Niedzwiecki, D; Torri, V; Andre, T; Sargent, DJ; Iveson, T

Published Date

  • June 20, 2017

Published In

Volume / Issue

  • 35 / 18_suppl

Start / End Page

  • LBA1 - LBA1

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2017.35.18_suppl.lba1